Children rarely get ill from COVID-19. Why should they be vaccinated?
- While most children do not get sick enough to be hospitalized, MIS-C occurs in about 1 in 1000 children who have had Covid, including those with mild illness.
- Children who get mild illness could pass the infection along to peers or adults at higher risk.
- The vaccine is not perfect protection against infection. But, the more people in any group (family, classroom, town, state, etc.) who are vaccinated, the better the group’s protection.
Which vaccine has been approved?
- Pfizer-BioNTech’s COVID-19 mRNA vaccine has emergency use authorization for children ages 5 to 15 years old. The vaccine has been named Comirnaty. Children under 12 years old will receive a dose 1/3 that of 12 and over.
(100% effective in preventing COVID-19 in children ages 12 through 15. The vaccine is 91% effective in preventing severe illness with COVID-19 in people age 16 and older. Early research also suggests that the vaccine is 96% effective at preventing severe disease with COVID-19 caused by the delta variant)
The Science Behind COVID-19 Vaccines by Healthy Children, American Academy of Pediatrics
Dr. Paul Offit of CHOP, infectious disease and vaccine expert, discusses COVID-19 illness and vaccination for teens and young adults.
COVID-19 and Myocarditis (excerpted from the American Academy of Pediatrics):
Across all ages, the risk of myocarditis was almost 16 times higher for people with COVID-19 compared to those who aren’t infected. The myocarditis risk is 37 times higher for infected children under 16 years and seven times higher for infected people ages 16-39 compared to their uninfected peers. Males ages 12-29 years — the group with the highest rates of myocarditis after vaccination — 39 to 47 cases of myocarditis for every million second doses of vaccine. [Ed. ~0.004%] Benefits of vaccination outweigh the risks.
Read the full article: COVID-19 Vaccination & Myocarditis Risk in Children